Appropriate dosing of burosumab in tumor-induced osteomalacia
Author:
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology, Diabetes and Metabolism
Link
https://link.springer.com/content/pdf/10.1007/s00198-022-06617-2.pdf
Reference5 articles.
1. Crotti C, Zucchi F, Alfieri C, Caporali R, Varenna M (2022) Long-term use of burosumab for the treatment of tumor-induced osteomalacia. Osteoporos Int 4:1–6. https://doi.org/10.1007/s00198-022-06516-6
2. Jan de Beur SM et al (2021) Burosumab for the treatment of tumor-induced osteomalacia. J Bone Miner Res 36:627–635. https://doi.org/10.1002/jbmr.4233
3. Imanishi Y et al (2021) Interim analysis of a phase 2 open-label trial assessing burosumab efficacy and safety in patients with tumor-induced osteomalacia. J Bone Miner Res 36:262–270. https://doi.org/10.1002/jbmr.4184
4. Hartley IR, Collins MT (2021) Burosumab for tumor-induced osteomalacia: not enough of a good thing. J Bone Miner Res 36:2453–2454. https://doi.org/10.1002/jbmr.4318
5. Insogna KL et al (2018) A randomized, double-blind, placebo-controlled, phase 3 trial evaluating the efficacy of burosumab, an anti-FGF23 antibody, in adults with X-linked hypophosphatemia: week 24 primary analysis. J Bone Miner Res 33:1383–1393. https://doi.org/10.1002/jbmr.3475
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Preoperative evaluation and orthopedic surgical strategies for tumor-induced osteomalacia;Journal of Bone Oncology;2024-04
2. Serum Phosphorus as a Driver of Skeletal Morbidity in Fibrous Dysplasia;The Journal of Clinical Endocrinology & Metabolism;2023-11-17
3. Occipital bone and tumor-induced osteomalacia: a rare tumor site for an uncommon paraneoplastic syndrome;Archives of Osteoporosis;2023-07-12
4. “Non-phosphaturic” Variant of Phosphaturic Mesenchymal Tumor of the Middle Ear Expressing Multiple Phosphatonins;Ear, Nose & Throat Journal;2023-01-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3